Introducing glycoprotein IIb/IIIa inhibitor therapy to air medical practice.

  title={Introducing glycoprotein IIb/IIIa inhibitor therapy to air medical practice.},
  author={Michael A. Frakes},
  journal={Air medical journal},
  volume={20 6},
INTRODUCTION In patients with myocardial infarction, platelet aggregation inhibition with glycoprotein IIb/IIIa antagonists helps restore and maintain coronary blood flow when administered alone, with fibrinolytics, or with angioplasty. This article evaluates whether an adequate number of patients transported by an air medical program could benefit from flight team administration of these agents and describes the implementation issues surrounding a treatment protocol. METHODS A retrospective… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…